Kardiyak Resenkronizasyon Tedavisi Endikasyonları ve Hasta Seçimi

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.000000000000106

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14;:]. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am J Cardiol. 2009 Jan 15;103(2):238-42. doi: 10.1016/j.amjcard.2008.08.069. Epub 2008 Nov 12. PMID: 19121443.

Borgquist R, Carlsson M, Markstad H, et al. Cardiac Resynchronization Therapy Guided by Echocardiography, MRI, and CT Imaging: A Randomized Controlled Study. JACC Clin Electrophysiol. 2020;6(10):1300-1309. doi:10.1016/j.jacep.2020.05.011 Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6(4):369-380. doi:10.1054/jcaf.2000.20841

Sauer WH, Bristow MR. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. J Interv Card Electrophysiol. 2008;21(1):3-11. doi:10.1007/s10840-007-9170-5

Ellenbogen KA, Wood MA, Klein HU. Why should we care about CARE-HF?. J Am Coll Cardiol. 2005;46(12):2199-2203. doi:10.1016/j.jacc.2005.07.057

Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. Congest Heart Fail. 2008;14(2):66-74. doi:10.1111/j.1751-7133.2008.07613.x

Reynolds CR, Gold MR. Cardiac resynchronization therapy in mild heart failure: a review of the REVERSE and MADIT-CRT trials. Curr Cardiol Rep. 2010;12(5):367-373. doi:10.1007/s11886-010-0125-6

Sapp JL, Sivakumaran S, Redpath CJ, et al. Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure. N Engl J Med. 2024;390(3):212-220. doi:10.1056/NEJMoa2304542

Beck H, Curtis AB. Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block. Curr Heart Fail Rep. 2016;13(5):230-236. doi:10.1007/s11897-016-0299-3

Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis. Europace. 2015;17(2):267-273. doi:10.1093/europace/euu214

Holzmeister J, Gorcsan J 3rd, Ruschitzka F. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2014;370(6):580-581. doi:10.1056/NEJMc1315288

Tofield A. Echocardiography-guided cardiac resynchronization therapy trial stopped prematurely. Eur Heart J. 2013;34(48):3679.

Thibault B, Harel F, Ducharme A, et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation. 2013;127(8):873-881. doi:10.1161/CIRCULATIONAHA.112.001239

Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(1):111-118. doi:10.1016/s0735-1097(02)01932-0

Tolosana JM, Hernandez Madrid A, Brugada J, et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol. 2008;102(4):444-449. doi:10.1016/j.amjcard.2008.04.008

Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150. doi:10.1056/NEJMoa032423

Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J. 2012;163(2):260-7.e3. doi:10.1016/j.ahj.2011.11.014

Gervais R, Leclercq C, Shankar A, et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail. 2009;11(7):699-705. doi:10.1093/eurjhf/hfp074

Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123(10):1061-1072. doi:10.1161/CIRCULATIONAHA.110.960898

Gold MR, Thébault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012;126(7):822-829. doi:10.1161/CIRCULATIONAHA.112.097709

Birnie DH, Ha A, Higginson L, et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. 2013;6(6):1190-1198. doi:10.1161/CIRCHEARTFAILURE.113.000380

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.000000000000106

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14;:]. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am J Cardiol. 2009 Jan 15;103(2):238-42. doi: 10.1016/j.amjcard.2008.08.069. Epub 2008 Nov 12. PMID: 19121443.

Borgquist R, Carlsson M, Markstad H, et al. Cardiac Resynchronization Therapy Guided by Echocardiography, MRI, and CT Imaging: A Randomized Controlled Study. JACC Clin Electrophysiol. 2020;6(10):1300-1309. doi:10.1016/j.jacep.2020.05.011 Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6(4):369-380. doi:10.1054/jcaf.2000.20841

Sauer WH, Bristow MR. The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective. J Interv Card Electrophysiol. 2008;21(1):3-11. doi:10.1007/s10840-007-9170-5

Ellenbogen KA, Wood MA, Klein HU. Why should we care about CARE-HF?. J Am Coll Cardiol. 2005;46(12):2199-2203. doi:10.1016/j.jacc.2005.07.057

Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. Congest Heart Fail. 2008;14(2):66-74. doi:10.1111/j.1751-7133.2008.07613.x

Reynolds CR, Gold MR. Cardiac resynchronization therapy in mild heart failure: a review of the REVERSE and MADIT-CRT trials. Curr Cardiol Rep. 2010;12(5):367-373. doi:10.1007/s11886-010-0125-6

Sapp JL, Sivakumaran S, Redpath CJ, et al. Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure. N Engl J Med. 2024;390(3):212-220. doi:10.1056/NEJMoa2304542

Beck H, Curtis AB. Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block. Curr Heart Fail Rep. 2016;13(5):230-236. doi:10.1007/s11897-016-0299-3

Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis. Europace. 2015;17(2):267-273. doi:10.1093/europace/euu214

Holzmeister J, Gorcsan J 3rd, Ruschitzka F. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2014;370(6):580-581. doi:10.1056/NEJMc1315288

Tofield A. Echocardiography-guided cardiac resynchronization therapy trial stopped prematurely. Eur Heart J. 2013;34(48):3679.

Thibault B, Harel F, Ducharme A, et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation. 2013;127(8):873-881. doi:10.1161/CIRCULATIONAHA.112.001239

Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(1):111-118. doi:10.1016/s0735-1097(02)01932-0

Tolosana JM, Hernandez Madrid A, Brugada J, et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol. 2008;102(4):444-449. doi:10.1016/j.amjcard.2008.04.008

Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150. doi:10.1056/NEJMoa032423

Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J. 2012;163(2):260-7.e3. doi:10.1016/j.ahj.2011.11.014

Gervais R, Leclercq C, Shankar A, et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail. 2009;11(7):699-705. doi:10.1093/eurjhf/hfp074

Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123(10):1061-1072. doi:10.1161/CIRCULATIONAHA.110.960898

Gold MR, Thébault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012;126(7):822-829. doi:10.1161/CIRCULATIONAHA.112.097709

Birnie DH, Ha A, Higginson L, et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. 2013;6(6):1190-1198. doi:10.1161/CIRCHEARTFAILURE.113.000380